Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (751-760 of 874) with videos related to

Pageof 88
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastomaMarcio H Malogolowkin, Howard Katzenstein, Mark D Krailo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2025
Relation of pulmonary diffusing capacity changes to HRCT chest and V/Q SPECT findings at short-term and intermediate follow-up after COVID-19: a prospective cohort study (The secure study)Thora Wesenberg Helt, Rie Skovly Thomsen, Jan Christensen, et al.
BMC Research Notes|September 9, 2017
Prevalence and significance of Mycoplasma genitalium in women living with HIV in DenmarkAnne Marie Rosendahl Madsen, Kristina Thorsteinsson, Anne-Mette Lebech, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2016
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapyAraz Marachelian, Ami Desai, Frank Balis, et al.
Journal of Clinical Immunology|June 2, 2025
Genetics in a Danish Common Variable Immunodeficiency CohortCamilla Heldbjerg Drabe, Mira Marie Laustsen, Hanne Vibeke Marquart, et al.
BMC Cancer|November 9, 2016
Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADEKristina Thorsteinsson, Merete Storgaard, Terese L Katzenstein, et al.
The Journal of Infectious Diseases|March 5, 2004
Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variationLeslie G Louie, Wendy E Hartogensis, Rachael P Jackman, et al.
BMC Infectious Diseases|August 24, 2019
Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADEKristina Thorsteinsson, Steen Ladelund, Merete Storgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabineKimberly Y Smith, Camlin Tierney, Katie Mollan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 21, 2023
Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort: Short title: Decline in HbA1c after elexacaftor/tezacaftor/ivacaftor treatmentBibi Uhre Nielsen, Mette Frahm Olsen, Inger Hee Mabuza Mathiesen, et al.
Pageof 88

Showing results (751-760 of 874) with videos related to

Sort By:
Pageof 88
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastomaMarcio H Malogolowkin, Howard Katzenstein, Mark D Krailo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2025
Relation of pulmonary diffusing capacity changes to HRCT chest and V/Q SPECT findings at short-term and intermediate follow-up after COVID-19: a prospective cohort study (The secure study)Thora Wesenberg Helt, Rie Skovly Thomsen, Jan Christensen, et al.
BMC Research Notes|September 9, 2017
Prevalence and significance of Mycoplasma genitalium in women living with HIV in DenmarkAnne Marie Rosendahl Madsen, Kristina Thorsteinsson, Anne-Mette Lebech, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2016
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapyAraz Marachelian, Ami Desai, Frank Balis, et al.
Journal of Clinical Immunology|June 2, 2025
Genetics in a Danish Common Variable Immunodeficiency CohortCamilla Heldbjerg Drabe, Mira Marie Laustsen, Hanne Vibeke Marquart, et al.
BMC Cancer|November 9, 2016
Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADEKristina Thorsteinsson, Merete Storgaard, Terese L Katzenstein, et al.
The Journal of Infectious Diseases|March 5, 2004
Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variationLeslie G Louie, Wendy E Hartogensis, Rachael P Jackman, et al.
BMC Infectious Diseases|August 24, 2019
Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADEKristina Thorsteinsson, Steen Ladelund, Merete Storgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabineKimberly Y Smith, Camlin Tierney, Katie Mollan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 21, 2023
Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort: Short title: Decline in HbA1c after elexacaftor/tezacaftor/ivacaftor treatmentBibi Uhre Nielsen, Mette Frahm Olsen, Inger Hee Mabuza Mathiesen, et al.
Pageof 88